Publication

Neuroendocrine tumors of the pancreas.

Davies, Karen
; 
Conlon, Kevin C
Authors
Davies, Karen
 Conlon, Kevin C
Advisors
Editors
Other Contributors
Departments
Department of Surgery, Trinity College Dublin, The Adelaide and Meath Hospital incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland.
Date
2009-04
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adenoma, Islet Cell
Algorithms
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Islet Cell
Catheter Ablation
Chemoembolization, Therapeutic
Evidence-Based Medicine
Gastrins
Glucagon
Humans
Insulin
Pancreatic Neoplasms
Quality of Life
Somatostatin
Survival Analysis
Treatment Outcome
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Current gastroenterology reports
URI
http://hdl.handle.net/10147/251854
Abstract
Pancreatic endocrine tumors are rare neoplasms accounting for less than 5% of pancreatic malignancies. They are broadly classified into either functioning tumors (insulinomas, gastrinomas, glucagonomas, VIPomas, and somatostatinomas) or nonfunctioning tumors. The diagnosis of these tumors is difficult and requires a careful history and examination combined with laboratory tests and radiologic imaging. Signs and symptoms are usually related to hormone hypersecretion in the case of functioning tumors and to tumor size or metastases with nonfunctioning tumors. Surgical resection remains the treatment of choice even in the face of metastatic disease. Further development of novel diagnostic and treatment modalities offers potential to greatly improve quality of life and prolong disease-free survival for patients with pancreatic endocrine tumors.
Language
en
Citation
Neuroendocrine tumors of the pancreas. 2009, 11 (2):119-27 Curr Gastroenterol Rep
ISSN
1534-312X
eISSN
ISBN
DOI
PMID
19281699
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval